Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Do HMG CoA Reductase Inhibitors Affect Abeta Levels?
Authors not listed
Seattle Institute for Biomedical and Clinical Research · 2002
Abstract
Recent evidence suggests that there is a significant overlap between AD and cerebrovascular disease. In fact, AD and cerebrovascular disease may share some of the same risk factors, including hypercholesterolemia. In addition, studies have suggested that the HMG Co-A reductase inhibitor lipid-lowering agents, known as "statins," decrease the risk of AD by up to 70%; however, effects differed by specific statin use. This study will compare two statins, simvastatin (which crosses the blood brain barrier) and pravastatin (which does not), with respect to their ability to alter blood and cerebrospinal fluid (CSF) levels of AD and inflammatory markers. The primary aim of the proposed study is to determine whether there is a reduction in Abeta with statins and whether the ability of the statin to cross the blood-brain barrier will affect its ability to decrease Abeta. If it can be demonstrated that statins alter AD-associated biomarkers, this would have broad implications for the treatment and prevention of AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Anonymous. (2002). Do HMG CoA Reductase Inhibitors Affect Abeta Levels?. <em>Seattle Institute for Biomedical and Clinical Research</em>. https://clinicaltrials.gov/study/NCT00303277
Vancouver
Anonymous. Do HMG CoA Reductase Inhibitors Affect Abeta Levels?. Seattle Institute for Biomedical and Clinical Research. 2002.
BibTeX
@misc{anon2002DoHMGC,
title = {Do HMG CoA Reductase Inhibitors Affect Abeta Levels?},
author = {Anonymous},
journal = {Seattle Institute for Biomedical and Clinical Research},
year = {2002},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Physical Activity and Health 2013
Citation only
The Associations Between Cardiovascular Risk Factors, Physical Activity, and Arterial Stiffness in Youth
Joanne Outtrim 2018
Open access · US-GOV
Preoperative Use of Wrist-worn Accelerometers to Measure Physical Activity in High-risk Elderly Patients
Ageing Research Reviews 2026
Open access · CC-BY
Age-related sarcopenia and the gut microbiome: mechanistic insights into the gut-muscle axis and potential microbiome based therapeutic interventions
Region Västerbotten 2012
Open access · US-GOV
Effects of Primary Prevention on Non-communicable Disease in Elderly People-An Intervention Study in 70 Year Old Men and Women, the Healthy Aging Initiative
University of Nottingham 2009
Open access · US-GOV
Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance in Older People
Regulatory Mechanisms in Biosystems 2026
Open access · CC-BY